_id

690da894ccc777a4e85d07f0

Ticker

ACAD

Name

ACADIA Pharmaceuticals Inc

Exchange

NASDAQ

Address

12830 El Camino Real, San Diego, CA, United States, 92130

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.acadia.com

Description

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin which completed Phase III clinical trial to treat the negative symptoms of schizophrenia; ACP-101, which completed phase III clinical trial for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 that completed phase II clinical trial for the treatment of Alzheimer's disease psychosis and Lewy Body Dementia with psychosis; ACP-711, which is in phase I clinical trial for the treatment of essential tremor; ACP-211 that is in phase I clinical trial for the treatment of treatment-resistant depression; ACP-2591 that is in Phase I development for Rett syndrome and Fragile X syndrome; and ACP-271, a GPR88 agonist used in evaluation of neurology and is in the IND-enabling stage. The company has a license agreement with Neuren Pharmaceuticals Limited to trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.

Last Close

26.68

Volume

1880081

Current Price

27.15

Change

1.7616191904047933

Last Updated

2025-11-28T11:46:18.286Z

Image

data:image/webp;base64,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

Ipo Date

2004-05-27T00:00:00.000Z

Market Cap

4197401088

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9722352941176472

Sentiment Sources

17

Rating

3.95

Target Price

29

Strong Buy

7

Buy

6

Hold

6

Sell

1

Strong Sell

0

Current Quarter

2025-09-30

Revenue

278633000

Cost Of Revenue

21647000

Gross Profit

256986000

Operating Expenses

221230000

Operating Income

35756000

Interest Expense

-

Pretax Income

44595000

Net Income

71779000

Eps

0.4206211544096103

Dividends Per Share

-

Shares Outstanding

169181817

Income Tax Expense

-27184000

EBITDA

47545000

Operating Margin

12.832650834610401

Total Other Income Expense Net

8839000

Cash

257995999

Short Term Investments

589023000

Receivables

139438000

Inventories

29097000

Total Current Assets

1076422000

Property Plant Equipment

53381000

Total Assets

1330771000

Payables

21747000

Short Term Debt

11783000

Long Term Debt

-

Total Liabilities

413499000

Equity

917272000

Depreciation

2950000

Change In Working Capital

-12519000

Cash From Operations

74288000

Capital Expenditures

388000

Cash From Investing

-79352000

Cash From Financing

9423000

Net Change In Cash

4359000

PE

16.0065

PB

5.051007225773817

ROE

7.82526884064923

ROA

5.393790516925902

FCF

73900000

Fcf Percent

0.26522343010339766

Piotroski FScore

4

Health Score

76

Deep Value Investing Score

5.5

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

9

Garp Investing Score

7

Growth Investing Score

5.5

Momentum Investing Score

7

Net Net Investing Score

4

Quality Investing Score

8.5

Value Investing Score

6

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

278633000

Quarters > 0 > income Statement > cost Of Revenue

21647000

Quarters > 0 > income Statement > gross Profit

256986000

Quarters > 0 > income Statement > operating Expenses

221230000

Quarters > 0 > income Statement > operating Income

35756000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

44595000

Quarters > 0 > income Statement > net Income

71779000

Quarters > 0 > income Statement > eps

0.4206211544096103

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

170650000

Quarters > 0 > income Statement > income Tax Expense

-27184000

Quarters > 0 > income Statement > EBITDA

47545000

Quarters > 0 > income Statement > operating Margin

12.832650834610401

Quarters > 0 > income Statement > total Other Income Expense Net

8839000

Quarters > 0 > balance Sheet > cash

257995999

Quarters > 0 > balance Sheet > short Term Investments

589023000

Quarters > 0 > balance Sheet > receivables

139438000

Quarters > 0 > balance Sheet > inventories

29097000

Quarters > 0 > balance Sheet > total Current Assets

1076422000

Quarters > 0 > balance Sheet > property Plant Equipment

53381000

Quarters > 0 > balance Sheet > total Assets

1330771000

Quarters > 0 > balance Sheet > payables

21747000

Quarters > 0 > balance Sheet > short Term Debt

11783000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

413499000

Quarters > 0 > balance Sheet > equity

917272000

Quarters > 0 > cash Flow > net Income

71779000

Quarters > 0 > cash Flow > depreciation

2950000

Quarters > 0 > cash Flow > change In Working Capital

-12519000

Quarters > 0 > cash Flow > cash From Operations

74288000

Quarters > 0 > cash Flow > capital Expenditures

388000

Quarters > 0 > cash Flow > cash From Investing

-79352000

Quarters > 0 > cash Flow > cash From Financing

9423000

Quarters > 0 > cash Flow > net Change In Cash

4359000

Quarters > 0 > ratios > PE

0.4206211544096103

Quarters > 0 > ratios > PB

5.051007225773817

Quarters > 0 > ratios > ROE

7.82526884064923

Quarters > 0 > ratios > ROA

5.393790516925902

Quarters > 0 > ratios > FCF

73900000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.26522343010339766

Quarters > 0 > health Score

76

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

264566000

Quarters > 1 > income Statement > cost Of Revenue

20734000

Quarters > 1 > income Statement > gross Profit

243832000

Quarters > 1 > income Statement > operating Expenses

211458000

Quarters > 1 > income Statement > operating Income

32374000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

40211000

Quarters > 1 > income Statement > net Income

26666000

Quarters > 1 > income Statement > eps

0.15808538009615783

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

168681000

Quarters > 1 > income Statement > income Tax Expense

13545000

Quarters > 1 > income Statement > EBITDA

35309000

Quarters > 1 > income Statement > operating Margin

12.236644164405101

Quarters > 1 > income Statement > total Other Income Expense Net

7837000

Quarters > 1 > balance Sheet > cash

253637000

Quarters > 1 > balance Sheet > short Term Investments

508359000

Quarters > 1 > balance Sheet > receivables

119686000

Quarters > 1 > balance Sheet > inventories

26124000

Quarters > 1 > balance Sheet > total Current Assets

960553000

Quarters > 1 > balance Sheet > property Plant Equipment

54538000

Quarters > 1 > balance Sheet > total Assets

1225555000

Quarters > 1 > balance Sheet > payables

20097000

Quarters > 1 > balance Sheet > short Term Debt

11693000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

403173000

Quarters > 1 > balance Sheet > equity

822382000

Quarters > 1 > cash Flow > net Income

26666000

Quarters > 1 > cash Flow > depreciation

-1159000

Quarters > 1 > cash Flow > change In Working Capital

21551000

Quarters > 1 > cash Flow > cash From Operations

63956000

Quarters > 1 > cash Flow > capital Expenditures

98541000

Quarters > 1 > cash Flow > cash From Investing

-43294000

Quarters > 1 > cash Flow > cash From Financing

15956000

Quarters > 1 > cash Flow > net Change In Cash

36642000

Quarters > 1 > ratios > PE

0.15808538009615783

Quarters > 1 > ratios > PB

5.5688100542083845

Quarters > 1 > ratios > ROE

3.242532059310636

Quarters > 1 > ratios > ROA

2.1758305420809347

Quarters > 1 > ratios > FCF

-34585000

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

-0.1307235245647589

Quarters > 1 > health Score

51

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

244317000

Quarters > 2 > income Statement > cost Of Revenue

20392000

Quarters > 2 > income Statement > gross Profit

223925000

Quarters > 2 > income Statement > operating Expenses

204635000

Quarters > 2 > income Statement > operating Income

19290000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

27779000

Quarters > 2 > income Statement > net Income

18987000

Quarters > 2 > income Statement > eps

0.11324164420163657

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

167668000

Quarters > 2 > income Statement > income Tax Expense

8792000

Quarters > 2 > income Statement > EBITDA

22241000

Quarters > 2 > income Statement > operating Margin

7.895480052554673

Quarters > 2 > income Statement > total Other Income Expense Net

8489000

Quarters > 2 > balance Sheet > cash

217696000

Quarters > 2 > balance Sheet > short Term Investments

463881000

Quarters > 2 > balance Sheet > receivables

113714000

Quarters > 2 > balance Sheet > inventories

22948000

Quarters > 2 > balance Sheet > total Current Assets

870942000

Quarters > 2 > balance Sheet > property Plant Equipment

54112000

Quarters > 2 > balance Sheet > total Assets

1132364000

Quarters > 2 > balance Sheet > payables

18095000

Quarters > 2 > balance Sheet > short Term Debt

11372000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

367127000

Quarters > 2 > balance Sheet > equity

765237000

Quarters > 2 > cash Flow > net Income

18987000

Quarters > 2 > cash Flow > depreciation

2951000

Quarters > 2 > cash Flow > change In Working Capital

-10879000

Quarters > 2 > cash Flow > cash From Operations

20323000

Quarters > 2 > cash Flow > capital Expenditures

98838000

Quarters > 2 > cash Flow > cash From Investing

-124049000

Quarters > 2 > cash Flow > cash From Financing

1838000

Quarters > 2 > cash Flow > net Change In Cash

-101893000

Quarters > 2 > ratios > PE

0.11324164420163657

Quarters > 2 > ratios > PB

5.9487272570458565

Quarters > 2 > ratios > ROE

2.4811921012705866

Quarters > 2 > ratios > ROA

1.6767576503668433

Quarters > 2 > ratios > FCF

-78515000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

-0.32136527544133237

Quarters > 2 > health Score

50

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

259602000

Quarters > 3 > income Statement > cost Of Revenue

21803000

Quarters > 3 > income Statement > gross Profit

237799000

Quarters > 3 > income Statement > operating Expenses

84296000

Quarters > 3 > income Statement > operating Income

153503000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

161085000

Quarters > 3 > income Statement > net Income

143742000

Quarters > 3 > income Statement > eps

0.8640314494896671

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

166362000

Quarters > 3 > income Statement > income Tax Expense

17343000

Quarters > 3 > income Statement > EBITDA

12202000

Quarters > 3 > income Statement > operating Margin

59.13012996818207

Quarters > 3 > income Statement > total Other Income Expense Net

7582000

Quarters > 3 > balance Sheet > cash

319589000

Quarters > 3 > balance Sheet > short Term Investments

436404000

Quarters > 3 > balance Sheet > receivables

104695000

Quarters > 3 > balance Sheet > inventories

21949000

Quarters > 3 > balance Sheet > total Current Assets

938318000

Quarters > 3 > balance Sheet > property Plant Equipment

50786000

Quarters > 3 > balance Sheet > total Assets

1187756000

Quarters > 3 > balance Sheet > payables

16192000

Quarters > 3 > balance Sheet > short Term Debt

9958000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

454963000

Quarters > 3 > balance Sheet > equity

732793000

Quarters > 3 > cash Flow > net Income

143742000

Quarters > 3 > cash Flow > depreciation

5214000

Quarters > 3 > cash Flow > change In Working Capital

30307000

Quarters > 3 > cash Flow > cash From Operations

40381000

Quarters > 3 > cash Flow > capital Expenditures

453000

Quarters > 3 > cash Flow > cash From Investing

122150000

Quarters > 3 > cash Flow > cash From Financing

1969000

Quarters > 3 > cash Flow > net Change In Cash

164440000

Quarters > 3 > ratios > PE

0.8640314494896671

Quarters > 3 > ratios > PB

6.163716492925014

Quarters > 3 > ratios > ROE

19.615634974679068

Quarters > 3 > ratios > ROA

12.10198054145801

Quarters > 3 > ratios > FCF

39928000

Quarters > 3 > ratios > Piotroski FScore

3

Quarters > 3 > ratios > fcf Percent

0.15380467022596128

Quarters > 3 > health Score

76

Valuation > metrics > PE

16.0065

Valuation > metrics > PB

5.051007225773817

Valuation > final Score

59.48992774226183

Valuation > verdict

34.2% Overvalued

Profitability > metrics > ROE

7.82526884064923

Profitability > metrics > ROA

6.668295519786849

Profitability > metrics > Net Margin

0.2576112664329064

Profitability > final Score

66

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.45079213145064934

Risk > metrics > Interest Coverage

12.120677966101695

Risk > final Score

100

Risk > verdict

Low

Liquidity > metrics > Current Ratio

32.10325082016105

Liquidity > metrics > Quick Ratio

31.2354607813898

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

44.311899457916155

Prev Valuations > 1

40.512727429541435

Prev Valuations > 2

40

Prev Profitabilities > 0

30

Prev Profitabilities > 1

23

Prev Profitabilities > 2

99

Prev Risks > 0

86

Prev Risks > 1

74

Prev Risks > 2

52

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:35.740Z